- P-ISSN 1010-0695
- E-ISSN 2288-3339
- Log In/Sign Up
- P-ISSN1010-0695
- E-ISSN2288-3339
Article Detail
Home > Article Detail
A Comparative Analysis of the Systems Related to the Production, Authorization, and Listing for Insurance of Herbal Medicine Products in South Korea and Taiwan
Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2012, v.33 no.3, pp.147-159
&
(2012). A Comparative Analysis of the Systems Related to the Production, Authorization, and Listing for Insurance of Herbal Medicine Products in South Korea and Taiwan. Journal of Korean Medicine, 33(3), 147-159.
- Downloaded
- Viewed
Abstract
Objectives: Systems related to the production, authorization, and listing for insurance of herbal medicine products were compared between South Korea and Taiwan to illuminate herbal medicine products system issues in South Korea. Methods: Papers, and laws and policies related to the production, authorization, and listing for insurance of herbal medicine products in South Korea and Taiwan are analyzed to create the primary documents. The documents from South Korea were screened with the advice of a specialist, while those from Taiwan have been verified through local investigation and with the help of a related specialist. The screened documents were then compared and analyzed in the order of the systems related to the production, authorization, and listing for insurance of herbal medicine products. Results: The systems related to the production of herbal medicine products satisfy GMP requirements in both countries, while Taiwan has more specialized systems related to the production of herbal medicine products and a more strict authorization program as compared to South Korea. While South Korea has most of the herbal medicine products classified as non-prescription drugs, Taiwan has them as prescription drugs. And while South Korea does not allow new herbal medicine products to be listed for insurance, Taiwan allows for once-a-year application toward listing for insurance. Conclusions: In order to ensure the safe and effective use of herbal medicine products, systems related to the production, authorization, and listing for insurance of herbal medicine products are to be established, while the categorization of medicine products principally used by Korean medicine doctors should be prepared. Furthermore, prescription by a Korean medicine doctor for new drugs made with natural products and their listing for insurance need to be encouraged.
- keywords
Reference
1
1. GLOBAL HEALTH CARE. Production & Distribution of Herbal Medicine(Ⅰ). Seoul: GLOBAL HEALTH CARE. 2011:51.
2
2. Committee on Chinese Medicine and Pharmacy, Department of Health. Yearbook of Herbal Medicine Industry 2009. Taipei: Committee on Chinese Medicine and Pharmacy, Department of Health. 2009:32,45.
3
3. Pusan National University School of Korean Medicine, Korea Institute of Oriental Medicine, The Association of Korean Oriental Medicine. 2009 Yearbook of Oriental Medicine in Korea. Pusan National University School of Korean Medicine, Korea Institute of Oriental Medicine, The Association of Korean Oriental Medicine. 2010:164.
4
4. The Bureau of National Health Insurance. Global Budget system. Taipei:The Bureau of National Health Insurance. 2011:9.
5
5. Committee on Chinese Medicine and Pharmacy, Department of Health. Yearbook of Herbal Medicine Industry 2009. Taipei: Committee on Chinese Medicine and Pharmacy, Department of Health. 2009:32,45.
6
6. Korea Institute of Oriental Medicine. The Polocy and Current Situation of Traditional Medicine in Taiwan. 1997.
7
7. Lee KG, Bae SH, Shin HK. An Investigaion about the Present States of Clinical Trial for Traditional Medicine in Korea, China, Taiwan and Japan.Korean Journal of Oriental Medicine. 2006:12(1):13-22.
8
8. Korea Food & Drug Administration. The study on development of clinical trial guideline for herbal medicine. Seoul:Korea Food & Drug Administration. 2007:117.
9
9. Ministry of Health & Welfare, Korea Institute of Oriental Medicine. The study on the development ways of Korean herbal industry and economic analysis. Ministry of Health & Welfare. 2004:82-84.
10
10. Committee on Chinese Medicine and Pharmacy, Department of Health. Laws and Regulations on Management of Chinese Medicine Products in Taiwan. Taipei: Committee on Chinese Medicine and Pharmacy, Department of Health. 2006:1-363.
11
11. Committee on Chinese Medicine and Pharmacy, Department of Health. Laws and Regulations on Management of Chinese Medicine and Pharmacy. Taipei: Committee on Chinese Medicine and Pharmacy, Department of Health. 2005:425-598.
12
12. Committee on Chinese Medicine and Pharmacy, Department of Health. Indicators on Chinese Medicine Administration. Taipei: Committee on Chinese Medicine and Pharmacy, Department of Health. 2010:13-27,45.
13
13. Committee on Chinese Medicine and Pharmacy, Department of Health. The compilation directing manual of the training exact effect for the Traditional Chinese Medicine GMP factories. Taipei: Committee on Chinese Medicine and Pharmacy, Department of Health. 2008:11-249.
14
14. CENTRAL INTELLIGENCE AGENCY(CIA). Available at: URL: https://www.cia.gov. Accessed July 10. 2011.
15
15. IMF statistics, Available at: URL: http://www.im f.org. Accessed July 10. 2011.
16
16. Department of Health. 2008 Statistics of General Health. Taipei:Department of Health. 2009:2-5.
17
17. Statistics Korea. Available at: URL: http://kostat. go.kr/portal/english/index.action. Accessed July 10. 2011.
18
18. Department of Health. 2008 The Statistical Annual Report of Medical Care Institution's Stataus & Hospital's Utilization. Taipei: Department of Health. 2009:340-343.
19
19. Ministry of Health & Welfare. The Second Plan of Korean Medicine Development 2011-2015. Seoul:Ministry of Health & Welfare. 2011:15.
20
20. GLOBAL HEALTH CARE. Production & Distribution of Herbal Medicine(Ⅰ). Seoul: GLOBAL HEALTH CARE. 2011:32-33.
21
21. Pusan National University, School of Korean Medicine, Korea Institute of Oriental Medicine, The Association of Korean Oriental Medicine. 2009 Yearbook of Oriental Meidicine in Korea. Pusan National University School of Korean Medicine, Korea Institute of Oriental Medicine, The Association of Korean Oriental Medicine. 2010:164,190-191.
22
22. Paik WH. Studies on the Improvement of GMP Regulation for Herbal Preparations. Seoul:Korea Food & Drug Administration. 2006:13.
23
23. The Association of Korean Oriental Medicine. Korean Medicine National Health Insurance Payment. Seoul:The Association of Korean Oriental Medicine. 2011:67.
24
24. Lee EK. Chater 4, The study on Improvement in System for revitalization of Herbal formulation. In: Kim Yunkyoung. The Study on Standardization of Herbal formulation. Korea Food & Drug Administration. 2011.
25
25. Korea Institute of Oriental Medicine. 2008 The Survey on the usage pattern of Oriental medicine. Seoul:Ministry of Health&Welfare. 2009:421-429.
26
26. Ohno K , Sekiya N , Namiki T , Kasahara Y, Chino A, Hirasaki Y, et al. Effects of Kampo Therapy for Inpatient on Medical Economics. Kampo Med. 2011;62(1):29-33.
27
27. Ogawa K, Oka H, Huji N. Cost-Effectiveness Analysis of Sho-saiko-to Therapy in the Liver Cirrhosis. Jpn Pharmacol Ther 1995;23(8):343-351.
28
28. Akase T, Akiba T, Isai H. Suzuki S. A Pharmacoepidemiological and Economic Study on the Medicinal Expenses for the Treatment of Colds. Kampo Med. 2000;50(4):655-663.
29
29. Korea Institute for Industrial Economics and Trade. The Research of China market system. Korea Institute for Industrial Economics and Trade. 2010;1-5.
30
30. Korea Institute of Oriental Medicine. Usage Pattern of Kampo Medicine in Japan In Japan Kampo Medicine trends. Korea Institute of Oriental Medicine e-brief.
31
31. Korea Food & Drug Administration. A study on the revaluation method of medicinal herb preparations. Seoul:Korea Food & Drug Administration. 2004:49-87.
- Downloaded
- Viewed
- 0KCI Citations
- 0WOS Citations
Other articles from this issue
- Research on Subjective Symptoms of Cancer Patients Using Questionnaire - Based on the 48 Patients Who Have Participated in Clinical Trial about Korean Red Ginseng -
- A Strategy Planning for Korean Medical Tourism Using A’WOT analysis
- The Effect of Acupuncture and Electro-acupuncture at ST41 on Experimentally-induced Intestinal Hypo-motility in Rats: Comparison between Pre-treatment and Post-treatment
- The Effects in Metabolism and Adipose Tissue Inflammation Induced by the Massa Medicata Fermentata on Obese Type 2 Diabetes Mouse Model
- Use of Korean Medicine among Cancer Patients
- Analysis of Biological Experiment on Socheongryong-tang (Xiaoqinglong-tang)
- Study on Sasang constitutional medical distributions of 258 patients with uterine myoma who underwent ultrasonography
- Preliminary Study to Develop a Korean Oriental Medical Assessment Tool for Syndrome Differentiation of Chronic Obstructive Pulmonary Disease
- A Report on Liver Function Tests of 82 Psoriasis Patients Taking Herbal Medication over 3 Months
- Mathematical Analysis of Constitutional Theory Based on Imbalanced Structure of Five Energy Elements
- Review of Interstitial Cystitis and Need for Therapeutic Strategy Using Traditional Korean Medicine
- Effects of YideungJetong-Tang on Peripheral Neuropathy Induced by Taxol and Compression Injury in the Rat Sciatic Nerve
- A Comparative Analysis of the Systems Related to the Production, Authorization, and Listing for Insurance of Herbal Medicine Products in South Korea and Taiwan
- Review of Pharmacological Effects of Coptidis Rhizoma and its Bioactive Compounds
- Effects in Metabolism and Adipocyte Inflammation Induced by the Complex Herbal Medicine composed of Cornus officinalis, Dioscorea rhizoma, Aurantii fructus, Mori folium in Obese Type 2 Diabetes Mouse Model
- Review of Red Ginseng in terms of Mechanisms for Pharmacodynamics and Toxicity
- more
Recommanded Articles
This website recommended the use the Chrome browser for journal website.